BNP Paribas Initiates Coverage on Stevanato Group (NYSE:STVN)

BNP Paribas began coverage on shares of Stevanato Group (NYSE:STVN) in a research note released on Monday morning, Marketbeat reports. The brokerage issued an outperform rating on the stock.

Separately, Stephens reiterated an overweight rating and issued a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of €33.63 ($35.77).

Stevanato Group Stock Performance

STVN stock opened at €27.31 ($29.05) on Monday. The stock has a market capitalization of $8.07 billion, a PE ratio of 46.29, a price-to-earnings-growth ratio of 2.93 and a beta of 0.70. Stevanato Group has a 12-month low of €23.00 ($24.47) and a 12-month high of €36.30 ($38.62). The company has a current ratio of 1.50, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. The stock’s 50 day simple moving average is €30.17 and its 200 day simple moving average is €29.46.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share for the quarter, missing the consensus estimate of €0.19 ($0.20) by (€0.01) (($0.01)). The firm had revenue of €320.60 million for the quarter, compared to the consensus estimate of €326.85 million. Stevanato Group had a net margin of 13.43% and a return on equity of 14.31%. Stevanato Group’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.19 earnings per share. As a group, research analysts forecast that Stevanato Group will post 0.67 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

Several institutional investors and hedge funds have recently bought and sold shares of the company. Conestoga Capital Advisors LLC lifted its stake in shares of Stevanato Group by 0.5% during the fourth quarter. Conestoga Capital Advisors LLC now owns 4,557,278 shares of the company’s stock worth $124,368,000 after buying an additional 23,190 shares during the period. Copeland Capital Management LLC grew its stake in Stevanato Group by 18.6% during the 4th quarter. Copeland Capital Management LLC now owns 2,088,778 shares of the company’s stock valued at $57,003,000 after acquiring an additional 327,960 shares in the last quarter. TimesSquare Capital Management LLC boosted its holdings in Stevanato Group by 64.2% in the 3rd quarter. TimesSquare Capital Management LLC now owns 2,032,361 shares of the company’s stock valued at $60,402,000 after purchasing an additional 794,391 shares during the last quarter. Sands Capital Management LLC boosted its holdings in Stevanato Group by 1.6% in the 4th quarter. Sands Capital Management LLC now owns 1,884,330 shares of the company’s stock valued at $51,423,000 after purchasing an additional 29,450 shares during the last quarter. Finally, Riverbridge Partners LLC lifted its holdings in shares of Stevanato Group by 78.1% in the 4th quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock worth $34,789,000 after acquiring an additional 559,070 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.